Biodegradation mechanism and rate, biocompatibility, and toxicity for novel Zn-Mg stent materials

新型锌镁支架材料的生物降解机制和速率、生物相容性和毒性

基本信息

  • 批准号:
    8957197
  • 负责人:
  • 金额:
    $ 44.2万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2015
  • 资助国家:
    美国
  • 起止时间:
    2015-08-01 至 2018-07-31
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION: Heart disease is of great societal interest due to its drastic impact on health in industrialized nations, especially in developed countries where obesity rates are high and the typical diet is not conducive to cardiovascular health. While invasive procedures are not desirable, they are often crucial to ensuring patient survival. The 5 million coronary stents administered world-wide each year remain present in the human artery for the lifetime of the patient. This has resulted in the emergence of several serious side effects. A bio absorbable metal stent that harmlessly erodes away over time could minimize the normal chronic risks associated with permanent stents. Mg- and Fe-based alloys currently pursued in designing such biodegradable stents have met with limited success. The research proposed at Michigan Tech aims to develop, for the first time, an alternative line of Zn-based stents that last 6-9 months in vivo. Preliminary study suggests that zinc exhibits ideal physiological corrosion behavior for bio absorbable stent application. The viability of a Zn-Mg stent, the corrosion behavior in vivo, and the degradation rate in the vascular environment remain open questions, and are the subjects of the proposed program. The overall feasibility of bio absorbable Zn-Mg stents will be evaluated. An in vivo evaluation of materials bio corrosion will be completed utilizing a recently developed arterial implantation method in which a sample with wire geometry is implanted into the arterial wall of a rat. Zn-Mg alloys will be prepared in order to tailor the material properties to accepted values of tensile strength, elongation to failure, and penetration rate. Our preliminary study has shown that the magnesium addition to zinc increases the mechanical strength. In addition, electro/chemically active Mg additions will lead to tunable rates of bio corrosion. The research will lead to selection and testing of a Zn-Mg alloy that meets the following criteria: i) keep corrosion rates close to the 0.02 mm/year value; ii) have >200 MPa yield strength, and >20% elongation to failure; and iii) exhibit biocompatibility similar to 316L stainless steel, industria standard for stent materials.
 产品说明:心脏病由于其对工业化国家的健康的巨大影响而引起巨大的社会兴趣,特别是在肥胖率高且典型饮食不利于心血管健康的发达国家。虽然侵入性手术不可取,但它们通常对确保患者生存至关重要。全世界每年使用的500万个冠状动脉支架在患者的一生中仍然存在于人体动脉中。这导致了一些严重的副作用的出现。随着时间的推移,无害地侵蚀掉的生物可吸收金属支架可以最大限度地减少与永久性支架相关的正常慢性风险。目前在设计这种可生物降解支架中所追求的Mg基和Fe基合金已经取得了有限的成功。密歇根理工大学提出的这项研究旨在首次开发一种锌基支架的替代产品线, vivo.初步研究表明,锌具有理想的生理腐蚀行为的生物可吸收支架应用。Zn-Mg支架的可行性、体内腐蚀行为和血管环境中的降解速率仍然是悬而未决的问题,并且是所提议项目的主题。将评价生物可吸收锌镁支架的总体可行性。将利用最近开发的动脉植入方法完成材料生物腐蚀的体内评价,其中将具有导丝几何形状的样品植入大鼠动脉壁。将制备锌镁合金,以定制材料性能,以接受 拉伸强度、断裂伸长率和渗透率的值。我们的初步研究表明,镁加入锌增加机械强度。此外,电/化学活性Mg添加将导致可调的生物腐蚀速率。该研究将导致选择和测试符合以下标准的锌镁合金:i)保持腐蚀速率接近0.02 mm/年值; ii)屈服强度>200 MPa,断裂伸长率>20%; iii)表现出与316 L不锈钢(支架材料的工业标准)相似的生物相容性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jeremy Goldman其他文献

Jeremy Goldman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jeremy Goldman', 18)}}的其他基金

Biodegradable Metal Stent Alloys for Vascular Applications
用于血管应用的可生物降解金属支架合金
  • 批准号:
    10643743
  • 财政年份:
    2023
  • 资助金额:
    $ 44.2万
  • 项目类别:
Therapeutic Lymphatic Collecting Vessel Regeneration by Directed Fluid Flow
通过定向流体流进行治疗性淋巴收集管再生
  • 批准号:
    8287227
  • 财政年份:
    2012
  • 资助金额:
    $ 44.2万
  • 项目类别:
The Regulation of Interstitial Flow in Experimental Lymphedema by Compression
实验性淋巴水肿压迫对间质血流的调节
  • 批准号:
    8013022
  • 财政年份:
    2010
  • 资助金额:
    $ 44.2万
  • 项目类别:
The Regulation of Interstitial Flow in Experimental Lymphedema by Compression
实验性淋巴水肿压迫对间质血流的调节
  • 批准号:
    7769809
  • 财政年份:
    2010
  • 资助金额:
    $ 44.2万
  • 项目类别:
The Regulation of VEGF-C by Interstitial Flow
间质流对 VEGF-C 的调节
  • 批准号:
    7515846
  • 财政年份:
    2008
  • 资助金额:
    $ 44.2万
  • 项目类别:
Augmentation of Lymphangiogenesis by Increased Fluid Channeling in Mouse Skin
通过增加小鼠皮肤中的液体通道来增强淋巴管生成
  • 批准号:
    7141151
  • 财政年份:
    2006
  • 资助金额:
    $ 44.2万
  • 项目类别:
Augmentation of Lymphangiogenesis by Increased Fluid Channeling in Mouse Skin
通过增加小鼠皮肤中的液体通道来增强淋巴管生成
  • 批准号:
    7267942
  • 财政年份:
    2006
  • 资助金额:
    $ 44.2万
  • 项目类别:
Mechanical Stretch and Vein Graft Intimal Hyperplasia
机械拉伸和静脉移植内膜增生
  • 批准号:
    6952906
  • 财政年份:
    2005
  • 资助金额:
    $ 44.2万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 44.2万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 44.2万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.2万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.2万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 44.2万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.2万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 44.2万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 44.2万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 44.2万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 44.2万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了